Delivery Order SPE2DB22D1106-SPE2DB25FEZW5
- Not listed
- The Defense Logistics Agency awarded a $5,636.48 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Veltassa 8.4 GM powder packets (30-count). The contract, classified as firm fixed price with no set-aside designation, is scheduled for ultimate completion by July 28, 2025. This delivery order is performed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical supply...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,037.15 firm fixed-price contract is for the delivery of Veltassa 8.4 GM powder packets, a medication used to treat hyperkalemia. The contract has an ultimate completion date of May 1, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Veltassa 8.4 GM Powder Packet 30S, a pharmaceutical product. The contract has a ceiling value of $1,211.08 and a period of performance through August 27, 2024. It is a firm fixed-price contract. AmerisourceBergen, a major pharmaceutical distributor, will deliver these medical supplies to support military treatment facilities and federal healthcare programs. This delivery...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,358.10, is for the delivery of the medication Veltassa 8.4 GM Powder Packet 30s. This is a firm fixed-price delivery order contract that runs through February 28, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Veltassa 8.4 GM powder packets. The firm-fixed-price contract has a ceiling value of $12,212.80 and a period of performance through March 15, 2024. This order is placed under an indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp with a potential value of $999,999,999.00 and a performance period...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office division. The $18,521.16 firm fixed price contract is for the supply of Veltassa 8.4 GM Powder Packet 30S, a pharmaceutical product. The contract has an ultimate completion date of October 8, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide range of medical commodities,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $5,510.17 firm fixed price contract is for the delivery of Veltassa 8.4 GM Powder Packet 30S, a specialty pharmaceutical product, to support military treatment programs and facilities. This delivery order was awarded under an indefinite delivery...
- This federal contract award is for the delivery of Veltassa 8.4 GM powder packets to the Defense Logistics Agency (DLA). The $1,936.65 firm fixed price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 24, 2024. The contract has an ultimate completion date of October 25, 2024 and is designated as a Delivery Order with no set-aside requirements. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This is a $1,057.81 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of VELTASSA 8.4 GM POWDER PACKET 30S. The order is placed against AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order has a completion date of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a pharmaceutical sourcing and distribution services company, for the supply of Veltassa 8.4 gram powder packets. The contract is a firm fixed price delivery order with a ceiling value of $4,213.02 and a completion date of April 2, 2024. AmerisourceBergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is the prime contractor. This award is...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEZW5Delivery Order
The Defense Logistics Agency awarded a $1,358.10 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Veltassa 8.4 gm powder packets (30-count units). This is a non-set-aside competitive award with an ultimate completion date of July 28, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The delivery order is issued as a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with the DLA. This delivery order falls under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. That prime contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Veltassa, a potassium-binding medication, represents the type of specialized pharmaceutical commodity delivered through this strategic contracting arrangement to support Defense Health Agency and other federal healthcare system requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 7/25/25 |